Personalized guide for timing blood-thinner reduction after a heart attack
Part of Heart & circulation clinical trials.
This study tests whether a personalized score (OPT-CAD) can help decide the best time to stop or reduce blood-thinning medication in people who have had a heart attack and a stent placed. It aims to balance preventing future heart issues while lowering the risk of bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with Acute Coronary Syndrome (ACS) and have received at least one drug-eluting stent (a small mesh tube) in your heart artery.
- You are able to take blood-thinning medication (dual antiplatelet therapy) for at least 12 months.
- You do not have a dangerously high risk of bleeding (determined by specific medical criteria).
- You are not allergic to aspirin, clopidogrel, or ticagrelor (common heart medicines).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether changing the timing and type of blood-thinner tablets after a heart stent is as safe and effective as continuing the same plan. It may help some people by simplifying treatment while preventing dangerous clotting after a coronary procedure.
This Phase 4 study tests a way to measure blood flow in heart arteries to help doctors choose the best stent plan. It may help improve safety and effectiveness for people having elective heart stent procedures for stable angina or certain heart attacks.
This study compares different blood-thinner (“antithrombotic”) strategies in people with atrial fibrillation or flutter who recently had a stent placed (PCI). It aims to find a plan that lowers clot risk while keeping bleeding risk as low as possible.
This study tests if doctors can safely use special eye scans (OCT) or angiography to decide when to stop taking two blood thinners (DAPT) after a heart attack and stent placement. It aims to reduce bleeding risks while still protecting your heart.
This trial tests if a shorter, lower dose of two blood thinners is safe and effective for patients with a recent heart attack or unstable angina who are at high risk for bleeding. It uses a special stent that might allow for less medication.
This trial tests ways to improve safety for people with high bleeding risk who take blood thinners after getting a heart stent. It aims to find better quality checks to prevent bleeding and clotting problems.
Hear when a new Acute Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.